<VariationArchive RecordType="classified" VariationID="55823" VariationName="NM_005236.3(ERCC4):c.1484_1488del (p.Thr495fs)" VariationType="Deletion" Accession="VCV000055823" Version="4" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-12-17" DateCreated="2015-10-19" MostRecentSubmission="2020-06-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="70481" VariationID="55823">
      <GeneList>
        <Gene Symbol="ERCC4" FullName="ERCC excision repair 4, endonuclease catalytic subunit" GeneID="2072" HGNC_ID="HGNC:3436" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="13920154" stop="13952348" display_start="13920154" display_stop="13952348" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="14014013" stop="14046204" display_start="14014013" display_stop="14046204" Strand="+" />
          </Location>
          <OMIM>133520</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005236.3(ERCC4):c.1484_1488del (p.Thr495fs)</Name>
      <CanonicalSPDI>NC_000016.10:13935413:AACTCAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="14029271" stop="14029275" display_start="14029271" display_stop="14029275" variantLength="5" positionVCF="14029270" referenceAlleleVCF="TAACTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="13935414" stop="13935418" display_start="13935414" display_stop="13935418" variantLength="5" positionVCF="13935413" referenceAlleleVCF="TAACTC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_005236.2:c.1484_1488del</Name>
      </OtherNameList>
      <ProteinChange>T495fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_463" sequenceAccession="LRG_463">
            <Expression>LRG_463:g.20260_20264del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.14029273_14029277del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.14029273_14029277del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005236.2" sequenceAccession="NM_005236" sequenceVersion="2" change="c.1484_1488delCTCAA">
            <Expression>NM_005236.2:c.1484_1488delCTCAA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.13935416_13935420del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.13935416_13935420del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011442.1" sequenceAccession="NG_011442" sequenceVersion="1" change="g.20260_20264del">
            <Expression>NG_011442.1:g.20260_20264del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005236.3" sequenceAccession="NM_005236" sequenceVersion="3" change="c.1484_1488del" MANESelect="true">
            <Expression>NM_005236.3:c.1484_1488del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005227.1" sequenceAccession="NP_005227" sequenceVersion="1" change="p.Thr495fs">
            <Expression>NP_005227.1:p.Thr495fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA143932" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="133520.0004" DB="OMIM" />
        <XRef Type="rs" ID="397509400" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005236.3(ERCC4):c.1484_1488del (p.Thr495fs) AND Fanconi anemia complementation group Q" Accession="RCV000049244" Version="27">
        <ClassifiedConditionList TraitSetID="10615">
          <ClassifiedCondition DB="MedGen" ID="C3808988">Fanconi anemia complementation group Q</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-10-03" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005236.3(ERCC4):c.1484_1488del (p.Thr495fs) AND Precursor B-cell acute lymphoblastic leukemia" Accession="RCV000722038" Version="2">
        <ClassifiedConditionList TraitSetID="2567">
          <ClassifiedCondition DB="MedGen" ID="C0349636">Precursor B-cell acute lymphoblastic leukemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-07-26" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2015-10-19" MostRecentSubmission="2020-06-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23623386</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2567" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10532" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">B Acute Lymphoblastic Leukemia</ElementValue>
                <XRef ID="HP:0004812" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pre-B-cell acute lymphoblastic leukemia</ElementValue>
                <XRef ID="HP:0004812" DB="Human Phenotype Ontology" />
                <XRef ID="277572006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Precursor B-cell acute lymphoblastic leukemia</ElementValue>
                <XRef ID="MONDO:0020511" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16920" />
                <XRef ID="16920" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/all.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2023</CitationText>
              </Citation>
              <XRef ID="99860" DB="Orphanet" />
              <XRef ID="C0349636" DB="MedGen" />
              <XRef ID="MONDO:0020511" DB="MONDO" />
              <XRef Type="primary" ID="HP:0004812" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10615" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17953" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Fanconi anemia complementation group Q</ElementValue>
                <XRef ID="MONDO:0014108" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FANCQ</ElementValue>
                <XRef Type="MIM" ID="615272" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA.</Attribute>
                <XRef ID="NBK1401" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15934" />
                <XRef ID="15934" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301575</ID>
                <ID Source="BookShelf">NBK1401</ID>
              </Citation>
              <XRef ID="84" DB="Orphanet" />
              <XRef ID="C3808988" DB="MedGen" />
              <XRef ID="MONDO:0014108" DB="MONDO" />
              <XRef Type="MIM" ID="615272" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1663708" SubmissionDate="2018-08-09" DateLastUpdated="2018-11-25" DateCreated="2018-11-25">
        <ClinVarSubmissionID localKey="NM_005236.2:c.1484_1488delCTCAA|MedGen:C0349636" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000853215" DateUpdated="2018-11-25" DateCreated="2018-11-25" Type="SCV" Version="1" SubmitterName="St. Jude Molecular Pathology, St. Jude Children's Research Hospital" OrgID="506672" OrganizationCategory="laboratory" OrgAbbreviation="SJCRH-MP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This is a frameshift alteration in which coding nucleotides 1484 through 1488 are deleted. This is predicted to change a Threonine to an Asparagine at codon 495, as well as shift the reading frame and result in a premature stop codon 6 amino acids downstream. Classification criteria: PVS1, PS3, PM2, PP1.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005236.2:c.1484_1488delCTCAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Pre-B-cell acute lymphoblastic leukemia</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0349636" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4387139</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="130773" SubmissionDate="2019-04-04" DateLastUpdated="2019-04-07" DateCreated="2013-07-05">
        <ClinVarSubmissionID localKey="133520.0004_FANCONI ANEMIA, COMPLEMENTATION GROUP Q" title="ERCC4, 5-BP DEL, 1484CTCAA_FANCONI ANEMIA, COMPLEMENTATION GROUP Q" />
        <ClinVarAccession Accession="SCV000077497" DateUpdated="2019-04-07" DateCreated="2013-07-05" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-05-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Spanish girl with Fanconi anemia complementation group Q (FANCQ; 615272), Bogliolo et al. (2013) identified compound heterozygous mutations in the ERCC4 gene: a 5-bp deletion in exon 8 (c.1484_1488delCTCAA), predicted to result in a frameshift and premature termination (Thr495AsnfsTer6), and a c.2065C-A transversion in exon 11, resulting in an arg689-to-ser (R689S; 133520.0005) substitution at a highly conserved residue in the nuclease active site. The mutations, which were identified by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder. Ectopic expression of R689S in embryonic fibroblasts from Ercc4-null mice did not complement mitomycin-C sensitivity, confirming the pathogenicity of the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">23623386</ID>
              </Citation>
              <XRef DB="OMIM" ID="615272" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC4" />
          </GeneList>
          <Name>ERCC4, 5-BP DEL, 1484CTCAA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, 1484CTCAA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="133520.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FANCONI ANEMIA, COMPLEMENTATION GROUP Q</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2692316" SubmissionDate="2020-02-27" DateLastUpdated="2020-06-28" DateCreated="2020-06-28">
        <ClinVarSubmissionID localKey="ERCC4_000002|OMIM:615272" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001364565" DateUpdated="2020-06-28" DateCreated="2020-06-28" Type="SCV" Version="1" SubmitterName="Leiden Open Variation Database" OrgID="506264" OrganizationCategory="other" OrgAbbreviation="LOVD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-10-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23623386</ID>
          </Citation>
          <Comment>Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_005236.2:c.1484_1488del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.14029273_14029277del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615272" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7043245</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2692316" TraitType="Disease" MappingType="XRef" MappingValue="615272" MappingRef="OMIM">
        <MedGen CUI="C3808988" Name="Fanconi anemia complementation group Q" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1663708" TraitType="Disease" MappingType="Name" MappingValue="Pre-B-cell acute lymphoblastic leukemia" MappingRef="Preferred">
        <MedGen CUI="C0349636" Name="Precursor B-cell acute lymphoblastic leukemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="130773" TraitType="Disease" MappingType="Name" MappingValue="FANCONI ANEMIA, COMPLEMENTATION GROUP Q" MappingRef="Preferred">
        <MedGen CUI="C3808988" Name="Fanconi anemia complementation group Q" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

